Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Johnny Page | M | - |
Bolden Therapeutics, Inc.
Bolden Therapeutics, Inc. BiotechnologyHealth Technology Bolden Therapeutics, Inc. is a biotechnology company that is developing first-in-class therapeutics to treat central nervous system diseases. The company's research facilities are based within Tufts Launchpad Biolabs, a leading incubator for next-generation powerhouse biotech startups located in Providence, RI. The company's scientific co-founders, Dr. Justin Fallon and Dr. Ashley E. Webb, have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons in the adult brain. Bolden is developing antisense oligonucleotides to modulate this genetically-validated target. The company was founded by Justin Fallon, Ashley E. Webb, and Johnny Page. Johnny Page has been the CEO since incorporation. | - |
Charles Polsky | M | - |
Bolden Therapeutics, Inc.
Bolden Therapeutics, Inc. BiotechnologyHealth Technology Bolden Therapeutics, Inc. is a biotechnology company that is developing first-in-class therapeutics to treat central nervous system diseases. The company's research facilities are based within Tufts Launchpad Biolabs, a leading incubator for next-generation powerhouse biotech startups located in Providence, RI. The company's scientific co-founders, Dr. Justin Fallon and Dr. Ashley E. Webb, have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons in the adult brain. Bolden is developing antisense oligonucleotides to modulate this genetically-validated target. The company was founded by Justin Fallon, Ashley E. Webb, and Johnny Page. Johnny Page has been the CEO since incorporation. | - |
Justin Fallon | M | - |
Bolden Therapeutics, Inc.
Bolden Therapeutics, Inc. BiotechnologyHealth Technology Bolden Therapeutics, Inc. is a biotechnology company that is developing first-in-class therapeutics to treat central nervous system diseases. The company's research facilities are based within Tufts Launchpad Biolabs, a leading incubator for next-generation powerhouse biotech startups located in Providence, RI. The company's scientific co-founders, Dr. Justin Fallon and Dr. Ashley E. Webb, have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons in the adult brain. Bolden is developing antisense oligonucleotides to modulate this genetically-validated target. The company was founded by Justin Fallon, Ashley E. Webb, and Johnny Page. Johnny Page has been the CEO since incorporation. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 3 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Ashley Webb
- Persoonlijk netwerk